Eguana Announces Closing of First Tranche of Private Placement of Units and Provides Corporate Update
08 déc. 2023 17h49 HE
|
Eguana Technologies Inc.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta,...
Business Update
07 déc. 2023 07h00 HE
|
Oxford BioMedica plc
Business Update Current contracted value signed in 2023 of £124 million, an increase of 47% compared to £85 million in the year ending 31 December 2022 (excluding COVID-19 vaccine manufacturing)On...
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
30 nov. 2023 01h00 HE
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – November 30, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for...
Clean Energy Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
28 nov. 2023 08h30 HE
|
Clean Energy Technologies, Inc.
- For the nine months ended September 30, 2023, revenues of $11.7 million represent an increase of 339% compared to $2.6 million for the same period in 2022 COSTA MESA, CA., Nov. 28, 2023 ...
GeoJunxion NV (ticker: GOJXN.AS) - Financiële en Operationele update Q1 FY 2023-24 (juli – september 2023)
16 nov. 2023 02h00 HE
|
GeoJunxion N.V.
Capelle aan den IJssel, 16 november 2023, GeoJunxion kondigt de publicatie aan van de financiële resultaten voor de eerste drie maanden van het boekjaar 2023-24, waaruit de eerste tekenen blijken van...
GeoJunxion NV (ticker: GOJXN.AS) - Financial & Business update Q1 FY 2023-24 (July – September 2023)
16 nov. 2023 02h00 HE
|
GeoJunxion N.V.
Capelle aan den IJssel, 16 November 2023, GeoJunxion announces the publication of its financial results for the first three months of the accounting year 2023-24, showing first evidence of slowdown in...
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 nov. 2023 16h04 HE
|
SeaStar Medical Holding Corporation
DENVER, Nov. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 nov. 2023 08h00 HE
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins...
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
09 nov. 2023 01h00 HE
|
Celyad Oncology SA
Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which allows to down-regulate several genes simultaneously, in Molecular Therapy – Nucleic...
IMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023
07 nov. 2023 08h30 HE
|
Imunon, Inc.
LAWRENCEVILLE, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...